Stanford University is beginning clinical trials on children as young as 6 months old with Pfizer’s COVID-19 vaccine. The mRNA shot will be given various doses to determine safety and the strongest dose possible with the fewest side effects.
Researchers will add more children to the trials later to determine efficacy of the shots. Additionally, Pfizer has also asked the FDA to amend its emergency use authorization to allow them “to expand the use of its vaccine to adolescents 12 to 15 years old.
SOURCE: Mercury News April 15, 2022